Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/IB2009/051815external-prioritypatent/WO2009136350A1/en
Application filed by PfizerfiledCriticalPfizer
Publication of TN2010000506A1publicationCriticalpatent/TN2010000506A1/en
Il est décrit des composés et leurs sels pharmaceutiquement acceptables, ces composés ayant la structure de formule (I) telle que définie dans la description . Des compositions pharmaceutiques correspondantes, des procédés de traitement, des procédés de synthèse et des intermédiaires sont également décrits.Compounds and their pharmaceutically acceptable salts are described, these compounds having the structure of formula (I) as defined in the description. Corresponding pharmaceutical compositions, methods of treatment, synthetic methods and intermediates are also described.
TNP2010000506A2009-05-042010-11-01
NEW CLASS OF SPIROPIPERIDINES FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES
TN2010000506A1
(en)
Compounds derived from fumarate; pharmaceutical composition comprising them; and its use in the treatment of an inflammatory or neurodegenerative disease.